UNION therapeutics A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About UNION therapeutics A/S
UNION therapeutics A/S (CVR number: 33963750K) is a company from GENTOFTE. The company reported a net sales of 0.6 mDKK in 2024, demonstrating a decline of -73 % compared to the previous year. The operating profit percentage was poor at -14126.6 % (EBIT: -87.7 mDKK), while net earnings were -98.9 mDKK. The profitability of the company measured by Return on Assets (ROA) was -43.3 %, which can be considered poor and Return on Equity (ROE) was -109.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -71 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. UNION therapeutics A/S's liquidity measured by quick ratio was 0.2 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.
Financial information
See financialsNet sales (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 118 912.00 | 34 393.00 | 2 299.00 | 621.00 | |
Gross profit | 9 049.00 | 125 090.00 | 34 393.00 | 2 299.00 | 621.00 |
EBIT | -64 328.00 | -51 939.00 | - 183 625.00 | - 160 042.00 | -87 726.00 |
Net earnings | -80 896.00 | -56 026.00 | - 214 304.00 | - 169 426.00 | -98 922.00 |
Shareholders equity total | -58 397.00 | 49 380.00 | -27 688.00 | -61 599.00 | - 150 064.00 |
Balance sheet total (assets) | 68 884.00 | 284 925.00 | 185 675.00 | 120 190.00 | 61 214.00 |
Net debt | 52 469.00 | - 154 116.00 | -51 781.00 | 19 108.00 | 84 520.00 |
Profitability | |||||
EBIT-% | -43.7 % | -533.9 % | -6961.4 % | -14126.6 % | |
ROA | -59.0 % | -23.1 % | -72.6 % | -79.6 % | -43.3 % |
ROE | -133.5 % | -94.7 % | -182.3 % | -110.8 % | -109.1 % |
ROI | -71.0 % | -30.2 % | -101.1 % | -119.5 % | -60.4 % |
Economic value added (EVA) | -61 914.74 | -49 980.10 | - 171 356.59 | - 152 568.71 | -78 518.03 |
Solvency | |||||
Equity ratio | -45.9 % | 17.3 % | -13.0 % | -33.9 % | -71.0 % |
Gearing | -152.2 % | 201.1 % | -387.3 % | -185.7 % | -81.4 % |
Relative net indebtedness % | -15.0 % | 158.0 % | 3761.8 % | 27964.6 % | |
Liquidity | |||||
Quick ratio | 1.6 | 4.1 | 2.2 | 0.6 | 0.2 |
Current ratio | 1.6 | 4.1 | 2.2 | 0.6 | 0.2 |
Cash and cash equivalents | 36 425.00 | 253 402.00 | 159 005.00 | 95 305.00 | 37 618.00 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | 169.9 % | 265.2 % | -3014.4 % | -21519.6 % | |
Credit risk | |||||
Credit rating | B | BBB | BB | B | B |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.